L-165041
Clinical data | |
---|---|
Pregnancy category |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C22H26O7 |
Molar mass | 402.443 g·mol−1 |
3D model (JSmol) | |
| |
|
L-165041 is a phenyloxyacetate PPARδ receptor agonist. It is less potent and PPARδ selective than GW 501516.[2]
See also
[edit]References
[edit]- ^ Iwashita A, Muramatsu Y, Yamazaki T, Muramoto M, Kita Y, Yamazaki S, et al. (March 2007). "Neuroprotective efficacy of the peroxisome proliferator-activated receptor delta-selective agonists in vitro and in vivo". The Journal of Pharmacology and Experimental Therapeutics. 320 (3): 1087–96. doi:10.1124/jpet.106.115758. PMID 17167170. S2CID 9595370.
- ^ Atta-ur-Rahman, Reitz AB (2005). Frontiers in Medicinal Chemistry, Volume 2. Bentham Science Publishers. pp. 244–. ISBN 978-1-608-05205-9. Retrieved 2 April 2013.